This site is intended for health professionals only

Published on 28 April 2009

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

Shire announce results from Annual General Meeting

teaser

Shire plc, the global specialty biopharmaceutical company, announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll can be viewed on the link below:

Shire



Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Oral vitamin A could become an alternative to isotretinoin for acne
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
What’s in my medicine and is it safe?
Studies highlight potential new option in treating bone loss
Assessment of safety profile of Stelara® for moderate to severe psoriasis
Connecting care and outcomes
New data on Selincro

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x